(1)
Bulut Gökten, D.; Mercan, R. Clinical Outcomes After Switching from Originator Infliximab to the Biosimilar Ixifi in Patients With Axial Spondyloarthritis: A Single-Center Study from Türkiye. Rheumatol Bul 2026, 34 (1), 4-20. https://doi.org/10.35465/wx09tq86.